RNU6-1110P

Across TCGA pan-cancer cohorts, RNU6-1110P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU6-1110P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1110P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1110P expression acts as an unfavorable survival marker, although some lineages such as LUSC and UCS show a favorable association.

KIRC, DLBC, and SKCM are the cancer types where RNU6-1110P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	IV	0.064	0.642	<.001	105	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	72	view →
SKCM	OS	Tertile	All	0.752	0.894	.001	54	view →
LUSC	DFS	Tertile	All	0.856	0.721	.002	54	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	45	view →
PAAD	OS	Tertile	All	0.226	0.599	<.001	36	view →
READ	OS	Tertile	II,III,IV	0.527	0.933	<.001	36	view →
KIRP	DFS	Tertile	All	0.465	0.870	.001	15	view →
UCS	DFS	Tertile	III,IV	1.000	0.222	.046	12	view →
LGG	OS	Median	All	0.925	0.865	.010	11	view →
LIHC	DFS	Tertile	All	0.098	0.530	.005	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU6-1110P–KIRC (DFS)

Open the KIRC breakdown →